Australian Clinical Labs Ltd (AU:ACL) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Australian Clinical Labs Ltd has announced a daily buy-back of its ordinary fully paid securities, acquiring 125,000 shares on the previous day. This move is part of an ongoing buy-back strategy, with the company having repurchased a total of 1,080,864 shares before the previous day. Investors may find this buy-back activity indicative of the company’s confidence in its stock value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.